Key facts
- Cutting Edge (Surgical Devices)’s last known valuation is $17.1M.
- It has raised $13.7M; the latest was Later Stage VC ($8.3M) in Jul 2024.
- Notable investors include BNP Paribas Développement, IRDI Capital Investissement, Sofilaro.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Cutting Edge (Surgical Devices)
- ·The full record, as it builds
Funding rounds
No funding rounds for Cutting Edge (Surgical Devices) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cutting Edge (Surgical Devices)
Manufacturer of eye surgery devices intended for the well-being of the patients. The company designs, develops, manufactures, and distributes intraocular implants and ophthalmic medical devices, and provides individual development opportunities through training and constant collaboration, enabling patients to improve their vision through the optimized operational processes provided by professional surgeons.
- Sector
- Healthcare
- HQ
- Montpellier, France
- Founded
- 2014
- Employees
- 33
- Website
- cutting-edge.fr/
- Ownership
- Privately Held (backing)
Cutting Edge (Surgical Devices) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cutting Edge (Surgical Devices) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cutting Edge (Surgical Devices) in its N-PORT filings yet. We sweep new filings monthly.